HIV Rash: What It Looks Like & When It Appears

An HIV rash is a flat or slightly raised, reddish or darkened skin eruption that often shows up during acute (early) HIV infection, usually within two to four weeks of exposure hiv.gov. It tends to cover the chest, back, or face, isn't usually itchy, and comes alongside fever and other flu-like symptoms. A rash alone can't confirm or rule out HIV. Only a test can.

The essentials: what an HIV rash actually is

HIV is a virus that attacks the immune system, and it moves through three stages: acute infection (a high viral load and very contagious), chronic infection or clinical latency (the virus stays active but quiet, often for a decade or more untreated), and AIDS, the most advanced stage CDC. The rash people search for belongs almost entirely to that first stage. It's one feature of what clinicians call acute retroviral syndrome, the body's early immune reaction as the virus replicates fast.

During acute infection the immune system mounts a strong response while viral levels surge, and that combination can spill out into the skin. The result is typically a maculopapular rash. "Macules" are flat colored spots and "papules" are small raised bumps, so you often see both together. On lighter skin it reads as pink or red; on darker skin it can look purplish, brown, or simply darker than surrounding skin, which is why it's easy to overlook. It usually isn't painful or intensely itchy, and it tends to fade on its own over a week or two as the acute phase settles.

A rash by itself proves nothing. Plenty of harmless viral illnesses, drug reactions, and allergies cause near-identical rashes, and many people with new HIV have no rash at all. Treat the rash as a prompt to test.

Symptoms: what the acute-HIV rash looks and feels like

Within two to four weeks after infection, many people develop flu-like symptoms: fever, chills, night sweats, muscle aches, sore throat, fatigue, swollen lymph nodes, mouth ulcers, and rash. About 90% of people get some version of this acute illness, and it peaks at the moment the viral load is highest, above a million copies per milliliter, when onward transmission risk is also at its highest StatPearls. A new rash plus fever after a recent risk deserves an urgent test rather than wait-and-see.

The acute-HIV rash has a few telling features:

• It's usually a diffuse spread of small flat-and-raised spots, not a single patch or a ring.
• It favors the upper body — chest, upper back, face, and neck — and can reach the palms and soles.
• It's generally not very itchy and not blistering, which helps separate it from poison ivy, shingles, or chickenpox.
• It arrives with systemic symptoms like fever, swollen glands, and sore throat, not on its own.
• It clears within roughly one to two weeks as the acute phase passes, but the virus does not go away with it.

After the acute phase, people often go years with no symptoms at all during clinical latency, even though the virus is still active. Normal-looking skin is not reassurance. Untreated, the immune system slowly erodes until the AIDS stage, defined by a CD4 count under 200 cells/mm³ or an opportunistic infection (a serious infection that takes hold only when immune defenses are down).

How to tell an HIV rash from common lookalikes

Because the early rash mimics so many things, clinicians lean on the surrounding clues — timing after a possible exposure, fever and swollen lymph nodes, mouth ulcers — rather than the rash's appearance alone. Use this as a rough guide, not a diagnosis:

Testing: the only way to know

Symptoms can neither confirm nor rule out HIV; a test can. Which test depends on how long it's been since the possible exposure, because each kind has a window period before it can detect infection reliably CDC:

• A nucleic-acid test (NAT) looks for the virus itself and can detect it from about 10 to 33 days after exposure. It's the earliest option, often used when acute symptoms like rash are present.
• A fourth-generation antigen/antibody lab test detects from about 18 to 45 days.
• Antibody and rapid (finger-stick or oral-swab) tests detect from about 23 to 90 days.

A negative result is conclusive only after the full window has passed with no exposure during it. If you test early because of a rash and it's negative, you'll likely need to repeat it later. The mechanics of each test and these windows are covered in our guide to hiv testing, and you can check the right timing in our when to test after exposure tool.

In practice, testing is quick and low-barrier. A rapid finger-stick or oral swab gives results in minutes, lab blood draws take longer but detect infection sooner, and testing is free at many health departments. At-home kits exist too — see hiv self-testing at home — just respect the window period, since an at-home antibody test taken too early can falsely reassure. When you're ready, you can get tested. People often test the day after a risk and treat the negative as final, but for early acute infection it's the NAT or a repeat test that settles it.

Treatment: the rash isn't what you treat

There's no cure for HIV; once people get it, they have it for life. But it's highly manageable CDC. If a test confirms HIV, the rash itself needs nothing special; it fades as the acute phase passes. What matters is starting antiretroviral therapy (ART) as soon as possible. ART is a combination of HIV medicines — drug classes include integrase inhibitors, NRTIs, NNRTIs, and protease inhibitors — available as single daily pills or combination regimens.

The goal of treatment is an undetectable viral load, and most people reach it within about six months of starting ART CDC. A 20-year-old who starts treatment before their CD4 count falls below 200 now has a life expectancy approaching the general population's Lancet HIV. That's the practical case for testing early and starting early. For a grounded look at day-to-day life on treatment, see 8 facts about living with hiv/aids.

Undetectable equals untransmittable. Across the PARTNER studies, mixed-status couples logged over a hundred thousand condomless sex acts with zero linked HIV transmissions while the positive partner stayed virally suppressed PARTNER, Lancet.

Prevention: stopping HIV before symptoms ever start

The core CDC prevention tools are condoms, PrEP, PEP, treatment-as-prevention (U=U), and regular testing. Which one fits depends on your timing and situation:

• PrEP is for people without HIV who may be exposed through sex or injection drug use; taken as prescribed it reduces HIV risk from sex by about 99%, and a confirmed negative test is required before starting CDC PrEP.
• PEP is the emergency option after a possible exposure: a 28-day course that must start within 72 hours, so it's a same-day urgent-care or ER conversation CDC PEP.
• Newer long-acting PrEP keeps improving: twice-yearly injectable lenacapavir produced zero infections among women in the PURPOSE 1 trial, the strongest HIV-prevention result yet WHO.

For people who are pregnant, perinatal HIV is largely preventable: with ART during pregnancy and labor plus newborn prophylaxis, the risk of passing HIV to the baby drops below 1%.

When to see a clinician

See a clinician promptly if a new rash shows up with fever, swollen glands, sore throat, or mouth ulcers in the weeks after a possible exposure. That cluster, at the time the virus is most contagious, is worth an urgent test rather than watchful waiting.

Move faster — same day — if the possible exposure was within the last 72 hours, because PEP can prevent infection only if it's started inside that window. After that, the door for PEP closes. And if you don't have symptoms but had a risk, still test on the right schedule; the absence of a rash means nothing about your status.